Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Blood–Brain Barrier—A Key Player in Multiple Sclerosis Disease Mechanisms
Thomas Gabriel Schreiner, Constantin Romanescu, Bogdan Ovidiu Popescu
Biomolecules (2022) Vol. 12, Iss. 4, pp. 538-538
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases
Tongli Chen, Yan Dai, Chenghao Hu, et al.
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Blood–Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models
Sarah E. Brandl, Markus Reindl
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12699-12699
Open Access | Times Cited: 28
Immune System Dysregulation in the Progression of Multiple Sclerosis: Molecular Insights and Therapeutic Implications
Zuber Khan, Sidharth Mehan, Ghanshyam Das Gupta, et al.
Neuroscience (2024) Vol. 548, pp. 9-26
Closed Access | Times Cited: 13
Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges
Kamran Sheikhi, Sara Ghaderi, Hassan Firouzi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access | Times Cited: 1
Unveiling the role of gut-brain axis in regulating neurodegenerative diseases: A comprehensive review
Himanshi Yadav, Jaldhi, Rati Bhardwaj, et al.
Life Sciences (2023) Vol. 330, pp. 122022-122022
Closed Access | Times Cited: 19
Targeting Vascular Impairment, Neuroinflammation, and Oxidative Stress Dynamics with Whole-Body Cryotherapy in Multiple Sclerosis Treatment
Angela Dziedzic, Karina Maciak, Elżbieta Miller, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3858-3858
Open Access | Times Cited: 6
Ginsenoside Rb1 alleviates blood-brain barrier damage and demyelination in experimental autoimmune encephalomyelitis mice by regulating JNK/ ERK/NF-κB signaling pathway
Yingying Song, Xiaojuan Zhang, Xinyan Han, et al.
Journal of Ethnopharmacology (2025), pp. 119448-119448
Closed Access
Oligodendrocyte Precursor Cell-Specific HMGB1 Knockout Reduces Immune Cell Infiltration and Demyelination in Experimental Autoimmune Encephalomyelitis Models
Gil‐Ran Kim, Jihye Seo, Bokyung Kim, et al.
Neuroscience Bulletin (2025)
Closed Access
The Glycocalyx: The Importance of Sugar Coating the Blood-Brain Barrier
Candis Dancy, Kaitlyn E. Heintzelman, Moriah E. Katt
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8404-8404
Open Access | Times Cited: 4
Blood–Brain Barrier Disruption in Neuroimmunological Disease
Fumitaka Shimizu, Masayuki Nakamori
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10625-10625
Open Access | Times Cited: 4
In Vitro Modeling of the Blood–Brain Barrier for the Study of Physiological Conditions and Alzheimer’s Disease
Thomas Gabriel Schreiner, Ioana Creangă-Murariu, Bogdan Ionel Tamba, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1136-1136
Open Access | Times Cited: 17
Interplay between Systemic Glycemia and Neuroprotective Activity of Resveratrol in Modulating Astrocyte SIRT1 Response to Neuroinflammation
Anna D. Grabowska, Mateusz Wątroba, Joanna Witkowska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11640-11640
Open Access | Times Cited: 9
Blood-Brain Barrier Disruption in Neuroimmunological Disease
Fumitaka Shimizu, Masayuki Nakamori
(2024)
Open Access | Times Cited: 3
Platelets and platelet-derived vesicles as an innovative cellular and subcellular platform for managing multiple sclerosis
Sanaz Mehdi-Alamdarlou, Fatemeh Ahmadi, Mohammad‐Ali Shahbazi, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 5, pp. 4675-4686
Open Access | Times Cited: 7
Integrating genetic and proteomic data to elucidate the association between immune system and blood-brain barrier dysfunction with multiple sclerosis risk and severity
Dongren Sun, Rui Wang, Qin Du, et al.
Journal of Affective Disorders (2024) Vol. 362, pp. 652-660
Closed Access | Times Cited: 2
The Role of Human Herpesvirus 6 Infection in Alzheimer’s Disease Pathogenicity—A Theoretical Mosaic
Constantin Romanescu, Thomas Gabriel Schreiner, Ilya Mukovozov
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3061-3061
Open Access | Times Cited: 11
The modulation effect of green tea and pumpkin oils on hyperlipidemia, oxidative stress, and hematological abnormalities in an experimental multiple sclerosis rat model
Nahed S. Lamloum, Hanan A. Soliman, Rasha R. Ahmed, et al.
Clinical Phytoscience (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal administration
Yasmine Labrak, Mireille Alhouayek, Ariane Mwema, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124237-124237
Closed Access | Times Cited: 1
Purinergic-associated immune responses in neurodegenerative diseases
Sara Carracedo, Agathe Launay, Paul-Alexandre Déchelle-Marquet, et al.
Progress in Neurobiology (2024) Vol. 243, pp. 102693-102693
Open Access | Times Cited: 1
Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier
Pablo Vargas-Rodríguez, Alejandro Cuenca-Martagón, Julia Castillo-González, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14117-14117
Open Access | Times Cited: 3
Lysophosphatidic acid receptor 1 influences disease severity in a mouse model of multiple sclerosis
Nagi Uemura, Nagisa Matsuo, Kazunao Taniyama, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Cerebrospinal fluid characteristics of patients presenting for evaluation of pediatric acute-neuropsychiatric syndrome
Rajdeep Pooni, Wynne Zheng, Meiqian Ma, et al.
Frontiers in Behavioral Neuroscience (2024) Vol. 18
Open Access
The blood–brain barrier: Gatekeeper and obstacle in neurodegenerative disorders
Mahmoud Bassiony, Marwa A. Ibrahem, Donia G. Youssef, et al.
Elsevier eBooks (2024), pp. 17-32
Closed Access
Stem Cells Attenuate the Inflammation Crosstalk Between Ischemic Stroke and Multiple Sclerosis: A Review
Molly Monsour, Jonah Gordon, Gavin Lockard, et al.
Cell Transplantation (2023) Vol. 32
Open Access | Times Cited: 1
PECAM-1 Is Down-Regulated in γδT Cells during Remission, but Up-Regulated in Relapse of Multiple Sclerosis
Michał Zarobkiewicz, Izabela Morawska, Wioleta Kowalska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3210-3210
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top